Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/ADM.0000000000000685 http://scihub22266oqcxt.onion/10.1097/ADM.0000000000000685 32404652!7236851!32404652     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32404652&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32404652.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Addict+Med 2020 ; 14 (4): e8-e9 Nephropedia Template TP {{tp|p=32404652|t=2020. Innovation During COVID-19: Improving Addiction Treatment Access |pdf=|usr=}}{{32404652}} gab.com Text Innovation During COVID-19: Improving Addiction Treatment Access JO: J Addict Med http://www.kidney.de/pget.php?&tw=1&pmid=32404652 #FOAvip : During the COVID-19 pandemic, many addiction treatment and harm reduction organizations have had to reduce their hours and services for people with substance use disorders, placing these individuals at increased risk of death. In order to address restricted treatment access during COVID-19, guidance from the Substance Abuse Mental Health Services Administration, the US Drug Enforcement Administration, and the US Department of Health and Human Services has allowed for use of audio-only telehealth encounters for buprenorphine induction without requiring an in-person evaluation or video interface. This has enabled innovations in order to try to meet the needs of the most vulnerable among us during the current pandemic. In this new regulatory environment, we established the Rhode Island Buprenorphine Hotline, a phone hotline which functions as a "tele-bridge" clinic where people with moderate to severe opioid use disorder can be linked with a DATA 2000 waivered provider who can provide an initial assessment and, if appropriate, prescribe buprenorphine for unobserved induction and linkage to outpatient treatment. In this correspondence we briefly share our experience developing this common sense approach to addressing the complex problem of access to treatment only now permissible due to regulatory changes during COVID-19. Twit Text FOAVip Innovation During COVID-19: Improving Addiction Treatment Access ????J Addict Med http://www.kidney.de/pget.php?&tw=1&pmid=32404652 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32404652 #FOAvip English Wikipedia <ref>{{Cite pmid|32404652}}</ref> Innovation During COVID-19: Improving Addiction Treatment Access #MMPMID32404652 Samuels EA; Clark SA; Wunsch C; Jordison Keeler LA; Reddy N; Vanjani R; Wightman RS J Addict Med 2020[Jul]; 14 (4): e8-e9 PMID32404652show ga : During the COVID-19 pandemic, many addiction treatment and harm reduction organizations have had to reduce their hours and services for people with substance use disorders, placing these individuals at increased risk of death. In order to address restricted treatment access during COVID-19, guidance from the Substance Abuse Mental Health Services Administration, the US Drug Enforcement Administration, and the US Department of Health and Human Services has allowed for use of audio-only telehealth encounters for buprenorphine induction without requiring an in-person evaluation or video interface. This has enabled innovations in order to try to meet the needs of the most vulnerable among us during the current pandemic. In this new regulatory environment, we established the Rhode Island Buprenorphine Hotline, a phone hotline which functions as a "tele-bridge" clinic where people with moderate to severe opioid use disorder can be linked with a DATA 2000 waivered provider who can provide an initial assessment and, if appropriate, prescribe buprenorphine for unobserved induction and linkage to outpatient treatment. In this correspondence we briefly share our experience developing this common sense approach to addressing the complex problem of access to treatment only now permissible due to regulatory changes during COVID-19. |*Coronavirus Infections/epidemiology/prevention & control[MESH] |*Opioid-Related Disorders/drug therapy/epidemiology/psychology[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/epidemiology/prevention & control[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Health Services Accessibility/*organization & administration[MESH] |Humans[MESH] |Infection Control/*organization & administration[MESH] |Narcotic Antagonists/*therapeutic use[MESH] |Opiate Substitution Treatment/*methods[MESH] |Organizational Innovation[MESH] |SARS-CoV-2[MESH] |Telemedicine/methods/organization & administration[MESH]Innovation During COVID-19: Improving Addiction Treatment Access (epmc).pdf DeepDyve Pubget Overpricing